Specialists in the exploration and production of iodine and halogen based specialty chemical derivatives.
Q3 2017 Market Update – Seems quite positive “a landmark period for Iofina – The Group produced more iodine than expected and began implementing management’s strategic expansion plans by starting the construction of IO#7, at a time when global iodine prices continue to recover”.
I don’t like the Net Debt here (almost 100% of Mkt Cap) or the fact it’s never made a Profit. I am sure there’s a business case here for those that understand the industry – I do not.
16-Nov-2017 – 14.88p – £19.0m – PER n/a
Market Update – A reassurance that a new structure project is on progress and that it expects to meet or exceed the upper end of its H2 2017 production forecasts (225 – 240 MT).
It sounds like an interesting enough company. However, it’s still loss making and it’s got Net Debt of almost 100% of it’s Mkt Cap – I just can’t bring myself to consider investing in this at present.
23-Sep-2019 – 29p – £56m – PER 11
Interim Results For The 6 Months To End June 2019 – Revenue up 29%, EBITDA up 172% (the real Loss being -$0.3m), expanding in-line with it’s growth strategy.
Looks OK but really need to wait and see FY actuals.